Advisors Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,212
Closed -$26.9K 1484
2024
Q1
$26.9K Sell
1,212
-1,706
-58% -$41.6K ﹤0.01% 1343
2023
Q4
$80.3K Sell
2,918
-1,020
-26% -$24.6K ﹤0.01% 1217
2023
Q3
$87.9K Sell
3,938
-1,302
-25% -$33.5K ﹤0.01% 1205
2023
Q2
$133K Sell
5,240
-2,703
-34% -$65.5K ﹤0.01% 1175
2023
Q1
$177K Sell
7,943
-3,934
-33% -$95.1K ﹤0.01% 1137
2022
Q4
$282K Sell
11,877
-5,759
-33% -$134K 0.01% 1075
2022
Q3
$293K Sell
17,636
-3,177
-15% -$71.5K 0.01% 1063
2022
Q2
$414K Sell
20,813
-3,910
-16% -$79K 0.01% 995
2022
Q1
$682K Sell
24,723
-6,778
-22% -$194K 0.01% 918
2021
Q4
$1.3M Sell
31,501
-6,256
-17% -$276K 0.02% 755
2021
Q3
$1.75M Sell
37,757
-5,632
-13% -$246K 0.03% 631
2021
Q2
$1.74M Sell
43,389
-3,438
-7% -$147K 0.03% 635
2021
Q1
$2.52M Buy
46,827
+8,440
+22% +$486K 0.04% 503
2020
Q4
$1.88M Buy
38,387
+12,738
+50% +$590K 0.03% 576
2020
Q3
$833K Buy
25,649
+13,792
+116% +$438K 0.02% 759
2020
Q2
$307K Buy
11,857
+4,887
+70% +$122K 0.01% 1054
2020
Q1
$169K Sell
6,970
-91
-1% -$2.29K ﹤0.01% 1137
2019
Q4
$197K Buy
7,061
+645
+10% +$16.7K ﹤0.01% 1218
2019
Q3
$154K Buy
6,416
+3,032
+90% +$80.7K ﹤0.01% 1233
2019
Q2
$96K Buy
+3,384
New +$84.5K ﹤0.01% 1316

Other funds holding VCYT

Advisors Asset Management's VCYT Position: Q2 2024 in Review

Advisors Asset Management sold out of Veracyte (VCYT) in Q2 2024, closing a stake of 1,212 shares — an estimated $26.9K sold.

Advisors Asset Management first reported a position in VCYT in Q2 2019 and held it in 20 quarters. The position peaked at $2.52M in Q1 2021. 240 funds tracked by Wall St. Rank hold VCYT as of Q2 2024.

  • Advisors Asset Management reported no remaining Veracyte position as of Q2 2024 after selling out during the quarter.
  • Advisors Asset Management sold 1,212 Veracyte shares in Q2 2024, an estimated $26.9K.
  • Advisors Asset Management first reported a position in Veracyte in Q2 2019 and held it in 20 quarters.
  • Advisors Asset Management's Veracyte position peaked at $2.52M in Q1 2021.
  • 240 funds tracked by Wall St. Rank held Veracyte as of Q2 2024.

Based on Advisors Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.